Company Search:
Advanced Search
Sponsored Links
Biofrontera AG Company Snapshot
Biofrontera AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other pharmaceutical manufacturers in Europe: Photocure ASA of NORWAY (2019 sales of 281.56 million Norwegian Kroner [US$31.21 million] of which 52% was Hexvix/Cysview Own Sales), Malin Corporation Plc of IRELAND (34.90 million Euros [US$41.25 million] of which 100% was pharmaceutical products,), and Biosynex SA which is based in FRANCE (34.23 million Euros [US$40.46 million] of which 57% was Sale of Goods).

Sales Analysis. Biofrontera AG reported sales of 31.27 million Euro (US$36.96 million) for the year ending December of 2019. This represents an increase of 48.1% versus 2018, when the company's sales were 21.11 million Euro. Sales at Biofrontera AG have increased during each of the previous five years (and since 2014, sales have increased a total of 910%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biofrontera AG
  Stock Performance Chart for Biofrontera AG
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 3.74
(Figures in Euros )
1 Week 8.1%   13 Weeks -30.6%  
4 Weeks 7.2%   52 Weeks -42.0%  
Biofrontera AG Key Data:
  Ticker: B8F Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 31,265,000
(Year Ending Jan 2020).
Employees: 174
  Currency: Euros Market Cap: 167,736,625
  Fiscal Yr Ends: December Shares Outstanding: 44,849,365
  Share Type: Stammaktie Closely Held Shares: 26,800,922
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.